CM Management’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Sell |
25,000
-30,000
| -55% | -$232K | 0.18% | 66 |
|
|
2025
Q1 | $339K | Buy |
55,000
+15,000
| +38% | +$92.4K | 0.34% | 49 |
|
|
2024
Q4 | $204K | Sell |
40,000
-10,000
| -20% | -$51K | 0.18% | 54 |
|
|
2024
Q3 | $252K | Hold |
50,000
| – | – | 0.2% | 61 |
|
|
2024
Q2 | $206K | Sell |
50,000
-25,000
| -33% | -$103K | 0.19% | 61 |
|
|
2024
Q1 | $570K | Buy |
75,000
+25,000
| +50% | +$190K | 0.48% | 55 |
|
|
2023
Q4 | $417K | Sell |
50,000
-15,000
| -23% | -$125K | 0.34% | 61 |
|
|
2023
Q3 | $549K | Hold |
65,000
| – | – | 0.58% | 47 |
|
|
2023
Q2 | $618K | Sell |
65,000
-15,000
| -19% | -$143K | 0.6% | 48 |
|
|
2023
Q1 | $464K | Buy |
80,000
+6,782
| +9% | +$39.3K | 0.55% | 46 |
|
|
2022
Q4 | $594K | Buy |
73,218
+13,218
| +22% | +$107K | 0.71% | 48 |
|
|
2022
Q3 | $552K | Buy |
60,000
+7,500
| +14% | +$69K | 0.62% | 53 |
|
|
2022
Q2 | $599K | Buy |
52,500
+7,500
| +17% | +$85.6K | 0.64% | 49 |
|
|
2022
Q1 | $954K | Buy |
45,000
+33,822
| +303% | +$717K | 0.8% | 44 |
|
|
2021
Q4 | $324K | Buy |
11,178
+1,803
| +19% | +$52.3K | 0.24% | 81 |
|
|
2021
Q3 | $916K | Hold |
9,375
| – | – | 0.68% | 54 |
|
|
2021
Q2 | $1.22M | Hold |
9,375
| – | – | 0.88% | 43 |
|
|
2021
Q1 | $1.69M | Buy |
+9,375
| New | +$1.69M | 1.26% | 24 |
|